Publications by authors named "Kai-Michael Beeh"

Claim this Profile
[
[Asthma Management and Control in Germany in Light of Current Guidelines].
Roland Buhl, Charles Adarkwah, Annmarie Gähler, Kathrin Kahnert, Sylva Mitterdiami, Kai-Michael Beeh

Pneumologie· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: up to 12 months interim analysis.
Gernot Rohde, Claus F Vogelmeier, Kai-Michael Beeh, Peter Kardos, Thomas Paulsson

Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler® and asthma control among adult asthmatic patients in Europe: The results of the Newton study.
Fulvio Braido, Kai-Michael Beeh, Carolina Cisneros Serrano, Anh Tuan Dinh-Xuan, Lilla Tamási

Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis.
Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler, Saskia Krüger

Pulm Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.
Kai-Michael Beeh, Jing Claussen, Dhvani Shah, Alan Martin, Robyn Kendall

Int J Chron Obstruct Pulmon Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of long-acting triple therapy for chronic obstructive pulmonary disease (COPD) in practice: The ELETHON physicians' survey].
Kai-Michael Beeh, Saskia Krüger

Pneumologie· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs of patients with COPD in Germany: a retrospective, cross-sectional study.
Felix J F Herth, Claus F Vogelmeier, Franziska C Trudzinski, Henrik Watz, Dirk Skowasch, Kai-Michael Beeh

ERJ Open Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to move towards more sustainable asthma care in Europe: an expert opinion paper.
Christer Janson, Alex Wilkinson, Hanna Hisinger-Mölkänen, Bernardino Alcázar Navarrete, Kai-Michael Beeh

Breathe (Sheff)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.
Mirco Govoni, Michele Bassi, Luca Girardello, Germano Lucci, François Rony, Kai-Michael Beeh

Respir Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany.
Claus F Vogelmeier, Kai-Michael Beeh, Peter Kardos, Thomas Paulsson, Gernot Rohde

Ther Adv Respir Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study.
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter

Int J Chron Obstruct Pulmon Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fränce Hardtstock, Rachel K Knapp

Int J Chron Obstruct Pulmon Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial.
Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler, Saskia Krüger

Int J Chron Obstruct Pulmon Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of guideline awareness on the counseling of patients with acute cough among general practitioners and pharmacy personnel.
Peter Kardos, Kai-Michael Beeh, Ulrike Sent, Guido Bissmann

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial.
Kai-Michael Beeh, Piotr Kuna, Massimo Corradi, Isabelle Viaud, Alessandro Guasconi

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Therapy Podcast-COVID-19: Research and Real-World Experiences from the Editorial Board.
Kai Michael Beeh, Nazia Chaudhuri, Timothy J Craig, Alan Kaplan, Marcus Peter Kennedy

Pulm Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INTREPID: single- multiple-inhaler triple therapy for COPD in usual clinical practice.
David M G Halpin, Sally Worsley, Afisi S Ismaila, Kai-Michael Beeh, Dawn Midwinter

ERJ Open Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum.
Dave Singh, Michele Bassi, Deborah Balzano, Germano Lucci, Aida Emirova, Kai Michael Beeh

J Cell Mol Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.
Dave Singh, Henrik Watz, Kai Michael Beeh, Oliver Kornmann, Brian Leaker

Eur Respir J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Therapy 2020 Update and Podcast: Meet the Journal's Editors-in-Chief.
Kai-Michael Beeh, Rajiv Dhand

Pulm Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Mirco Govoni, Michele Bassi, Stefano Vezzoli, Germano Lucci, Aida Emirova, Kai Michael Beeh

Respir Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Dave Singh, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Leaker

Respir Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study.
Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, Alexia Richard, Weihua Cao

Int J Chron Obstruct Pulmon Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Therapy: Looking Back on 2018 and Forward to 2019.
Kai-Michael Beeh

Pulm Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
Peter Kardos, Kai-Michael Beeh, Ulrike Sent, Tobias Mueck, Heidemarie Gräter

BMC Pharmacol Toxicol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis